Guangsheng Li , Ningyi Ma , Weiwei Wang , Jian Chen , Jingfang Mao , Guoliang Jiang , Kailiang Wu
{"title":"Dose-averaged linear energy transfer within the gross tumor volume of non-small-cell lung cancer affects the local control in carbon-ion radiotherapy","authors":"Guangsheng Li , Ningyi Ma , Weiwei Wang , Jian Chen , Jingfang Mao , Guoliang Jiang , Kailiang Wu","doi":"10.1016/j.radonc.2024.110584","DOIUrl":null,"url":null,"abstract":"<div><h3>Background and purpose</h3><div>High linear energy transfer (LET) radiation exhibits stronger tumor-killing effect. However, the correlation between LET and the therapeutic efficacy in Carbon-ion radiotherapy (CIRT) for locally advanced non-small-cell lung cancer (LA-NSCLC) is currently not clear. This study aimed to investigate the relationship between the dose-averaged LET (<span><math><msub><mrow><mi>LET</mi></mrow><mi>d</mi></msub></math></span>) distribution within tumor and local recurrence for LA-NSCLC treated with CIRT.</div></div><div><h3>Methods and materials</h3><div>An analysis of 62 consecutive patients with LA-NSCLC who underwent CIRT from 2018 to 2022 was conducted. The <span><math><msub><mrow><mi>LET</mi></mrow><mi>d</mi></msub></math></span> distribution was calculated based on their treated plans, and the correlation between local recurrence and <span><math><msub><mrow><mi>LET</mi></mrow><mi>d</mi></msub></math></span>, relative biological effectiveness (RBE)-weighted doses (<span><math><msub><mi>D</mi><mrow><mi>RBE</mi></mrow></msub></math></span>) and clinical factors was investigated. Receiver operating characteristic (ROC) curve, log-rank test, and Cox regression analysis were performed based on that.</div></div><div><h3>Results</h3><div>16 patients were defined as local recurrence. Overall survival (OS) and local control (LC) at 24 months were 76.9 % and 73.2 %, respectively. The mean <span><math><msub><mrow><mi>LET</mi></mrow><mi>d</mi></msub></math></span> in internal gross tumor volume (iGTV) in the local recurrence group was 48.7 keV/µm, significantly lower than the mean <span><math><msub><mrow><mi>LET</mi></mrow><mi>d</mi></msub></math></span> of 53.2 keV/µm in the local control group (p = 0.016). No significant difference was observed in <span><math><msub><mi>D</mi><mrow><mi>RBE</mi></mrow></msub></math></span> between the local recurrence and local control groups. ROC curve analysis indicated that a percentage of 88 % of volume in iGTV receiving at least 40 keV/µm (<span><math><msub><mi>V</mi><mrow><mn>40</mn><mi>k</mi><mi>e</mi><mi>V</mi><mo>/</mo><mi>μ</mi><mi>m</mi></mrow></msub></math></span>) is the optimal threshold for predicting local recurrence (Area under curve (AUC) = 0.7636). The log-rank test and Cox regression analysis revealed that the <span><math><msub><mrow><mi>LET</mi></mrow><mi>d</mi></msub></math></span> value covering 98 % volume of iGTV (<span><math><mrow><msub><mrow><mi>LET</mi></mrow><mi>d</mi></msub><mn>98</mn><mo>%</mo></mrow></math></span>) was a significant risk factor for LC (p = 0.020).</div></div><div><h3>Conclusions</h3><div>Our study revealed an association between <span><math><msub><mrow><mi>LET</mi></mrow><mi>d</mi></msub></math></span> distribution and local recurrence in patients with LA-NSCLC. These findings suggest that lower <span><math><msub><mrow><mi>LET</mi></mrow><mi>d</mi></msub></math></span> may increase the probability of local recurrence. We suggest that <span><math><msub><mrow><mi>LET</mi></mrow><mi>d</mi></msub></math></span> distribution within iGTV should be routinely assessed in CIRT for lung cancer.</div></div>","PeriodicalId":21041,"journal":{"name":"Radiotherapy and Oncology","volume":"201 ","pages":"Article 110584"},"PeriodicalIF":4.9000,"publicationDate":"2024-10-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Radiotherapy and Oncology","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S016781402403562X","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"ONCOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Background and purpose
High linear energy transfer (LET) radiation exhibits stronger tumor-killing effect. However, the correlation between LET and the therapeutic efficacy in Carbon-ion radiotherapy (CIRT) for locally advanced non-small-cell lung cancer (LA-NSCLC) is currently not clear. This study aimed to investigate the relationship between the dose-averaged LET () distribution within tumor and local recurrence for LA-NSCLC treated with CIRT.
Methods and materials
An analysis of 62 consecutive patients with LA-NSCLC who underwent CIRT from 2018 to 2022 was conducted. The distribution was calculated based on their treated plans, and the correlation between local recurrence and , relative biological effectiveness (RBE)-weighted doses () and clinical factors was investigated. Receiver operating characteristic (ROC) curve, log-rank test, and Cox regression analysis were performed based on that.
Results
16 patients were defined as local recurrence. Overall survival (OS) and local control (LC) at 24 months were 76.9 % and 73.2 %, respectively. The mean in internal gross tumor volume (iGTV) in the local recurrence group was 48.7 keV/µm, significantly lower than the mean of 53.2 keV/µm in the local control group (p = 0.016). No significant difference was observed in between the local recurrence and local control groups. ROC curve analysis indicated that a percentage of 88 % of volume in iGTV receiving at least 40 keV/µm () is the optimal threshold for predicting local recurrence (Area under curve (AUC) = 0.7636). The log-rank test and Cox regression analysis revealed that the value covering 98 % volume of iGTV () was a significant risk factor for LC (p = 0.020).
Conclusions
Our study revealed an association between distribution and local recurrence in patients with LA-NSCLC. These findings suggest that lower may increase the probability of local recurrence. We suggest that distribution within iGTV should be routinely assessed in CIRT for lung cancer.
期刊介绍:
Radiotherapy and Oncology publishes papers describing original research as well as review articles. It covers areas of interest relating to radiation oncology. This includes: clinical radiotherapy, combined modality treatment, translational studies, epidemiological outcomes, imaging, dosimetry, and radiation therapy planning, experimental work in radiobiology, chemobiology, hyperthermia and tumour biology, as well as data science in radiation oncology and physics aspects relevant to oncology.Papers on more general aspects of interest to the radiation oncologist including chemotherapy, surgery and immunology are also published.